Poland
Languages

R&D relief

New tax scale and higher personal allowance

Major Changes in Legislation in 2022 Known as the Polish Deal

2 February 2022
The Polish Deal that entered into force on 1 January 2022 (with certain exceptions) involves a number of major changes both for companies and natural persons. The changes in 26 legal acts have been introduced in one big package. They have a great impact on crucial things from the taxpayer’s perspective, such as health insurance premiums, personal allowances, new tax thresholds and a range of other regulations. In the article below, we are going to discuss the most important ones the entrepreneurs surely cannot afford to overlook. We have already addressed these changes in detail on our blog, and we encourage you to read it.

We talked about R&D tax relief

12 February 2018
The "Financing a company's development - new opportunities in 2018" conference, of which we were a Partner of, and the Poznan Science and Technology Park Adam Mickiewicz University Foundation was the organizer, can most certainly be deemed as successful.

R&D Relief Problem Areas - Employees' Salaries and Contributions

1 June 2017
Piotr WYRWA
The last blog entry concerning research and development relief (hereinafter: R&D relief) we ended with the conclusion that despite the liberal approach of the tax authorities, which allow the relief to be used by a large group of taxpayers, the effective implementation of the relief requires an in-depth analysis of the regulations that govern it – especially in the context of the specific nature of a given taxpayer's business activity.

Research and Development Relief for (almost) Everyone!

27 April 2017
Piotr WYRWA
At the beginning of 2016, the so-called "research and development relief" (hereinafter: R&D relief) was introduced to the Personal Income Tax Act and the Corporate Income Tax Act. The mechanism of the relief lies in the possibility to deduct from taxable income expense specified in the Act (so-called "eligible costs") incurred by the taxpayer for research and development, despite the fact that the expense has already been recognized as tax deductible.